Loading AI tools
Indian pharmaceutical company From Wikipedia, the free encyclopedia
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad.[5][6][2][7] The company manufactures and custom synthesizes generic APIs, intermediates.[8][9] The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals.[10] Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.[11]
 | This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (March 2023) |
 Divi's Laboratories' logo | |
| Formerly | Divi's Research Centre |
|---|---|
| Company type | Public |
| ISIN | INE361B01024 |
| Industry | Pharmaceuticals |
| Founded | 12 October 1990 |
| Headquarters | Divi Towers, Cyber Hills, Gachibowli, , India |
Key people | |
| Products | Active Pharmaceutical Ingredients Nutraceuticals |
| Services | Custom synthesis |
| Revenue |  ₹9,073 crore (US$1.1 billion) [1] (2022) |
| ₹3,683 crore (US$440 million) [1] (2022) | |
| ₹2,960 crore (US$350 million) [1] (2022) | |
| Total assets | ₹13,374 crore (US$1.6 billion) [1] (2022) |
| Total equity | ₹11,728 crore (US$1.4 billion) [1] (2022) |
| Owner |
|
Number of employees | 13,884 (2020) |
| Subsidiaries |
|
| Website | divislabs |
| Footnotes / references [1][2][3][4] | |
In October 2024, Divi and his family were ranked 29th on Forbes list of India’s 100 richest tycoons, with a net worth of $9.2 billion.[12]
The company initially started developing commercial processes for the manufacturing of APIs and intermediates. Divi's Research Centre changed its name to Divi's Laboratories Limited in 1994 to signal its intent to enter the API and intermediates manufacturing industry.[13] Following this, the company established its first Manufacturing facility in 1995 at Choutuppal, Telangana.[1] In 2002, the company's second manufacturing facility commenced operations at Chippada near Visakhapatnam.[1]
The company went public with its initial public offering (IPO) on 17 February 2003.[14][13] In 2010, the company established a research centre in Hyderabad.[1]
Divi's Laboratories has between 60 and 85% global market share in generic naproxen, dextromethorphan and gabapentin APIs.[15] The company currently has between 20 and 30% global market share in pregabalin and methylamine APIs.[15] The company's API production is backwards integrated.[16]
Divi's Laboratories custom synthesis division provides contract development and manufacturing (CDMO) services and contract research and manufacturing services (CRAMS).[16] The company's clients include 6 of the top 10 largest multinational pharmaceutical companies.[17]
Divi's Nutraceuticals is a subsidiary of Divi's Laboratories, and manufacturers and supplies over 80 forms of carotenoids and vitamins.[10] Divi's Nutraceuticals was founded in 2006 as a subsidiary of Divi's Laboratories.[10]
The company has three manufacturing facilities and three R&D centres across India:[1]
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.
